The last decade has seen unprecedented acceleration of global warming due to anthropogenic climate change. Healthcare ...
Specific gene variants (PAM gene) cause GLP-1 resistance in 1 in 10 people, reducing the efficacy of type 2 diabetes drugs.
Background Patients with coexisting heart failure (HF) and diabetes mellitus are often prescribed complex treatment regimens, ...
Objectives In the USA, an estimated 40–50 million operations are performed annually, with high rates of adverse events. Since the 1980s, report cards have been used for outcome measures and to improve ...
Background Childhood anaemia remains a major public health challenge in low- and middle-income countries (LMICs). While ...
Objective To examine associations between participants’ perinatal factors, including harmonised birth weight and length, ...
Good Monday morning in New York City, where the kids are complaining that their student OMNY cards are too flimsy. This was the same site where Councilmember Susan Zhuang was arrested in 2024 for ...
WASHINGTON — With his sweeping election overhaul bill stalled in Congress, President Trump made a new play this week — tapping the power of the presidential pen to crack down on voting by mail across ...
The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current CF therapies.
Red-leaf lettuce is red due to anthocyanins, a class of polyphenolic pigments widely studied for their antioxidant properties ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. GLP-1 medications like semaglutide (Ozempic) have a number of surprisingly positive side effects, a massive new study ...
SGLT2 inhibitor therapy is linked to an increased risk for diabetic ketoacidosis in adults with T2D, particularly among those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results